# Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer

> **NCT00911092** · PHASE4 · COMPLETED · sponsor: **Centre Oscar Lambret** · enrollment: 50 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **PROCEDURE:** Blood sampling
- **RADIATION:** Radiation
- **DRUG:** Chemotherapy (Fluorouracil and Cisplatin)

## Key facts

- **NCT ID:** NCT00911092
- **Lead sponsor:** Centre Oscar Lambret
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-12
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2012-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00911092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00911092, "Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00911092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*